About
WMT AG is a biotech company based in Heidelberg developing precisely engineered small molecules that inhibit proliferation of overactivated cells using their novel Translational Trap technology, targeting diseases such as cancer, autoimmune disorders, and viral infections.
Explore WMT AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.